Fig. 1From: Characterization of immune checkpoints expression and lymphocyte densities of iranian breast cancer patients; the co-expression status and clinicopathological associatesImmunohistochemical staining of immune checkpoints. (A) H&E staining of a triple-negative breast cancer sample (x40 magnification). (B) high histologic grade in a sample (x400). (C-E) PD-1, LAG3, and PD-L1 staining of inflammatory cells (x400 magnifications, IHC staining). (F) PD-L1 staining in tumor cells (x400 magnifications, IHC staining)Back to article page